Maekawa I - Search Results

1

Reversal of resistance to doxorubicin with cepharanthine in murine P388 leukemia cells.

Fujimura T, Shibata H, Maekawa I, Furusawa S, Kawauchi H, Sasaki K, Takayanagi Y. Fujimura T, et al. Among authors: maekawa i. Jpn J Pharmacol. 1990 Dec;54(4):464-7. doi: 10.1254/jjp.54.464. Jpn J Pharmacol. 1990. PMID: 2087009 Free article.

2

[Assay of flow cytometry for the effect of cepharanthine on resistance to doxorubicin].

Kisara S, Hayashi A, Maekawa I, Furusawa S, Takayanagi Y, Sasaki K. Kisara S, et al. Among authors: maekawa i. Yakugaku Zasshi. 1992 Nov;112(11):837-45. doi: 10.1248/yakushi1947.112.11_837. Yakugaku Zasshi. 1992. PMID: 1484349 Japanese.

3

Effect of chlorpromazine on the toxicity of doxorubicin in mice.

Shibata H, Maekawa I, Furusawa S, Kawauchi H, Takayanagi Y, Sasaki K. Shibata H, et al. Among authors: maekawa i. Res Commun Chem Pathol Pharmacol. 1991 Mar;71(3):381-4. Res Commun Chem Pathol Pharmacol. 1991. PMID: 2047578

4

Influence of chlorpromazine on the toxicity of pirarubicin in mice.

Maekawa I, Shibata H, Furusawa S, Takayanagi Y, Sasaki K. Maekawa I, et al. Res Commun Chem Pathol Pharmacol. 1991 Apr;72(1):105-8. Res Commun Chem Pathol Pharmacol. 1991. PMID: 2052743

5

Potentiation of antitumor activity of pirarubicin by chlorpromazine in mice bearing doxorubicin-resistant P388 leukemia.

Shibata H, Maekawa I, Furusawa S, Kawauchi H, Takayanagi Y, Sasaki K. Shibata H, et al. Among authors: maekawa i. Res Commun Chem Pathol Pharmacol. 1990 Dec;70(3):359-62. Res Commun Chem Pathol Pharmacol. 1990. PMID: 2093213

6

Antitumor activity of acemetacin in mice bearing colon 26 carcinoma: a preliminary report.

Kisara S, Maekawa I, Sasaki K, Suzuki N, Hayashi A, Furusawa S, Takayanagi Y, Sasaki K. Kisara S, et al. Among authors: maekawa i. Res Commun Chem Pathol Pharmacol. 1993 Aug;81(2):247-50. Res Commun Chem Pathol Pharmacol. 1993. PMID: 8210703

7

[Clinical efficacy of high-dose cepharanthine for idiopathic thrombocytopenic purpura: retrospective multicenter analysis].

Takahata M, Hashino S, Fujimoto K, Endo T, Kobayashi N, Kurosawa M, Iwasaki H, Miyake T, Kohda K, Maekawa I, Sasagawa H, Tsustumi Y, Miyagishima T, Tanaka J, Imamura M, Teshima T. Takahata M, et al. Among authors: maekawa i. Rinsho Ketsueki. 2012 Dec;53(12):1983-90. Rinsho Ketsueki. 2012. PMID: 23318963 Japanese.

8

A case of myelodysplastic syndrome developed blastic crisis of chronic myelogenous leukemia with acquisition of major BCR/ABL.

Onozawa M, Fukuhara T, Takahata M, Yamamoto Y, Miyake T, Maekawa I. Onozawa M, et al. Among authors: maekawa i. Ann Hematol. 2003 Sep;82(9):593-5. doi: 10.1007/s00277-003-0703-4. Epub 2003 Jul 24. Ann Hematol. 2003. PMID: 12898186 Free article.

9

Hypokalemic rhabdomyolysis due to WDHA syndrome caused by VIP-producing composite pheochromocytoma: a case in neurofibromatosis type 1.

Onozawa M, Fukuhara T, Minoguchi M, Takahata M, Yamamoto Y, Miyake T, Kanagawa K, Kanda M, Maekawa I. Onozawa M, et al. Among authors: maekawa i. Jpn J Clin Oncol. 2005 Sep;35(9):559-63. doi: 10.1093/jjco/hyi139. Epub 2005 Jul 18. Jpn J Clin Oncol. 2005. PMID: 16027147

10

Treatment with low-dose cytosine arabinoside followed by administration of macrophage colony-stimulating factor prolongs the survival of patients with RAEB, RAEB-T, or leukemic phase myelodysplastic syndrome: a pilot study.

Fukuhara T, Miyake T, Maekawa I, Kurosawa M, Suzuki S, Noto S, Mori A, Chiba K, Toyoshima T, Hirano T, Morioka M, Tsutsumi Y, Okabe M, Kakinoki Y. Fukuhara T, et al. Among authors: maekawa i. Int J Hematol. 2000 Jun;71(4):366-71. Int J Hematol. 2000. PMID: 10905057 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters